학술논문
Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease
Document Type
Article
Author
Source
In: Trials . (Trials, December 2022, 23(1))
Subject
Language
English
ISSN
17456215